Rapid Micro Biosystems, Inc. (RPID)

NASDAQ: RPID · IEX Real-Time Price · USD
0.979
-0.011 (-1.11%)
Mar 28, 2024, 3:22 PM EDT - Market open
-1.11%
Market Cap 42.07M
Revenue (ttm) 22.52M
Net Income (ttm) -52.47M
Shares Out 42.50M
EPS (ttm) -1.22
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 116,354
Open 0.990
Previous Close 0.990
Day's Range 0.979 - 0.990
52-Week Range 0.740 - 1.410
Beta 1.28
Analysts n/a
Price Target n/a
Earnings Date May 3, 2024

About RPID

Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and customer support and validation services. Its platform automates and modernizes the manual microbial qu... [Read more]

Industry Medical Devices
Sector Healthcare
IPO Date Jul 15, 2021
Employees 193
Stock Exchange NASDAQ
Ticker Symbol RPID
Full Company Profile

Financial Performance

In 2023, RPID's revenue was $22.52 million, an increase of 31.44% compared to the previous year's $17.13 million. Losses were -$52.47 million, -13.71% less than in 2022.

Financial Statements

News

Rapid Micro Biosystems to Exhibit at the 2024 PDA Annual Meeting from March 25 - 27, 2024

Company to give technical presentation on its innovative Growth Direct® Rapid Sterility Application Company to give technical presentation on its innovative Growth Direct® Rapid Sterility Application

8 days ago - GlobeNewsWire

Rapid Micro Biosystems to Participate in the Virtual KeyBanc Life Sciences & MedTech Investor Forum

LOWELL, Mass., March 12, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solu...

15 days ago - GlobeNewsWire

Rapid Micro Biosystems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

LOWELL, Mass., March 06, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solu...

21 days ago - GlobeNewsWire

Rapid Micro Biosystems Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Guidance

Reports fourth quarter 2023 total revenue of $6.3 million , representing 45% growth compared to fourth quarter 2022

27 days ago - GlobeNewsWire

Rapid Micro Biosystems to Participate in Upcoming Investor Conferences

LOWELL, Mass., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solut...

4 weeks ago - GlobeNewsWire

Rapid Micro Biosystems to Announce Fourth Quarter and Full Year 2023 Financial Results on March 1, 2024

LOWELL, Mass., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission-critical automation solut...

5 weeks ago - GlobeNewsWire

Rapid Micro Biosystems Announces the Upcoming Availability of Rapid Sterility Application for the Growth Direct® System

The new Rapid Sterility application includes a novel, proprietary test kit that has been developed for use with the Company's fully automated Growth Direct system and delivers time to organism detecti...

2 months ago - GlobeNewsWire

Rapid Micro Biosystems Announces Preliminary Unaudited Fourth Quarter and Full Year 2023 Revenue

Full year 2023 total revenue expected to be between $22.4 million and $22.6 million, representing growth of over 30% compared to the prior year

2 months ago - GlobeNewsWire

Samsung Biologics selects Rapid Micro Biosystems' Growth Direct® platform to automate critical microbiology quality control testing

Companies share commitment to innovating quality control processes to meet biomanufacturing challenges such as scale, data integrity and accelerating time to market Companies share commitment to innov...

3 months ago - GlobeNewsWire

Rapid Micro Biosystems to Present at 42nd Annual J.P. Morgan Healthcare Conference

LOWELL, Mass., Jan. 03, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solut...

3 months ago - GlobeNewsWire

Top 5 Health Care Stocks That Could Lead To Your Biggest Gains in January - Corcept Therapeutics (NASDAQ:CORT), Kintara Therapeutics (NASDAQ:KTRA)

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

Other symbols: CORTKTRAMISTMOTS
3 months ago - Benzinga

Rapid Micro Biosystems Reports Third Quarter 2023 Financial Results

Reports third quarter 2023 total revenue of $6.1 million , representing growth of 30% compared to third quarter 2022

5 months ago - GlobeNewsWire

Rapid Micro Biosystems to Announce Third Quarter 2023 Financial Results on November 3, 2023

LOWELL, Mass., Oct. 19, 2023 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission-critical automation solut...

5 months ago - GlobeNewsWire

Rapid Micro Biosystems to Exhibit at the 2023 PDA Pharmaceutical Microbiology Conference from October 2 – 4

LOWELL, Mass., Sept. 29, 2023 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solu...

6 months ago - GlobeNewsWire

Rapid Micro Biosystems to Participate in the Virtual Gilmartin Group Emerging Growth Company Showcase

LOWELL, Mass., Sept. 19, 2023 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solu...

6 months ago - GlobeNewsWire

Rapid Micro Biosystems to Participate in the Morgan Stanley 21st Annual Global HealthCare Conference

LOWELL, Mass., Sept. 06, 2023 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solu...

7 months ago - GlobeNewsWire

Rapid Micro Biosystems Reports Second Quarter 2023 Financial Results

Reports second quarter 2023 total revenue of $5.0 million , representing growth of 30% compared to second quarter 2022

8 months ago - GlobeNewsWire

Rapid Micro Biosystems to Announce Second Quarter 2023 Financial Results on August 4, 2023

LOWELL, Mass., July 20, 2023 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission-critical automation solut...

9 months ago - GlobeNewsWire

Rapid Micro Biosystems Announces Appointment of Kirk Malloy, Ph.D. as Chair of its Board of Directors

LOWELL, Mass., July 18, 2023 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solut...

9 months ago - GlobeNewsWire

Rapid Micro Biosystems Reports First Quarter 2023 Financial Results

Reports first quarter 2023 total revenue of $5.0 million , representing growth of 21% , compared to first quarter 2022

11 months ago - GlobeNewsWire

Rapid Micro Biosystems Announces the Appointment of Michael Wysocki as Senior Vice President, Sales and Marketing

LOWELL, Mass., May 04, 2023 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation soluti...

11 months ago - GlobeNewsWire

Rapid Micro Biosystems to Announce First Quarter 2023 Financial Results on May 5, 2023

LOWELL, Mass., April 13, 2023 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solu...

1 year ago - GlobeNewsWire

Rapid Micro Biosystems Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Full Year 2023 Guidance

Reports fourth quarter 2022 commercial revenue of $4.4 million

1 year ago - GlobeNewsWire

Rapid Micro Biosystems to Participate in the Cowen 43rd Annual Health Care Conference

LOWELL, Mass., Feb. 28, 2023 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solut...

1 year ago - GlobeNewsWire

Rapid Micro Biosystems to Announce Fourth Quarter and Full Year 2022 Financial Results on March 3, 2023

LOWELL, Mass., Feb. 16, 2023 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solut...

1 year ago - GlobeNewsWire